The company has not filed an annual or quarterly report since its Q2 FY2017 10-Q, filed Aug 8, 2017. Its latest SEC filing is a SC 13G from Feb 13, 2018.
10-Q for Q2 FY2017, filed Aug 8, 2017
The sections below describe the company as of the FY2016 annual report.
Sells catheters and scoring balloons for treating arterial blockages to hospitals and physicians; also sells, rents and services laser systems and supplies tools to remove pacemaker and defibrillator leads.
10-K for FY2016, filed Feb 24, 2017We develop, manufacture, market and distribute single-use medical devices used in minimally invasive procedures within the cardiovascular…View ↗
Vascular Intervention (“VI”): Our broad portfolio of VI devices consists of laser and aspiration catheters, AngioSculpt® scoring balloon…View ↗
Laser, service, and other: Our proprietary excimer laser system, the CVX-300®, is the only laser system approved in the United States…View ↗
Our primary LM products include the GlideLight™ and SLS™ II; laser sheaths; Lead Locking Devices; and our mechanical tools, including the…View ↗
Our products are purchased principally by hospitals or physicians, which typically bill various third-party payers, such as governmental…View ↗
Hospitals and physicians are the main purchasers. Spectranetics sells directly to end users and through international distributors.
10-K for FY2016, filed Feb 24, 2017Our products are purchased principally by hospitals or physicians, which typically bill various third-party payers, such as governmental…View ↗
The Company sells to end-users in the U.S. and internationally as well as to certain international distributors. Sales to international…View ↗
International Medical includes product availability in over 65 countries outside of the U.S. and Canada, including our direct sales…View ↗
We sell our products through direct sales and distributors in Japan, China and an expanding set of countries in the Asia Pacific and Latin…View ↗
10-Q for Q2 FY2017, filed Aug 8, 2017
−$24.6MView ↗
8-K, filed Aug 9, 2017
On August 9, 2017, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Company, with the Company continuing…View ↗
8-K, filed Jun 30, 2017
On June 27, 2017, The Spectranetics Corporation, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the…View ↗
New vascular products
The older report described pursuing products through licensing and acquisition; the latest lists AngioSculpt scoring balloons and Stellarex drug-coated balloons in its vascular portfolio.
10-K for FY2013, filed Feb 28, 2014 10-K for FY2016, filed Feb 24, 2017executing on new products in development and obtaining new products through licensing and acquisition;View ↗
More lead-extraction tools The older report set out expanding lead-management tools to include mechanical extraction tools; the latest lists mechanical sheaths and the Bridge Occlusion Balloon among its products.
Competes with Medtronic, Boston Scientific, C.R. Bard, Cook Medical, QT Vascular, Biotronik, and Cardiovascular Systems
10-K for FY2016, filed Feb 24, 2017The medical device industry is highly competitive, subject to rapid change and significantly affected by new product introductions and…View ↗
Loading...
